The estimated Net Worth of Robert L Nussbaum is at least $6.45 million dollars as of 13 June 2023. Robert Nussbaum owns over 7,086 units of Invitae Corp stock worth over $11,387 and over the last 9 years he sold NVTA stock worth over $5,638,517. In addition, he makes $802,739 as Chief Medical Officer at Invitae Corp.
Sign up
Robert Nussbaum NVTA stock SEC Form 4 insiders trading
Robert has made over 25 trades of the Invitae Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 7,086 units of NVTA stock worth $9,779 on 13 June 2023.
The largest trade he's ever made was selling 29,783 units of Invitae Corp stock on 9 July 2020 worth over $1,017,089. On average, Robert trades about 9,129 units every 62 days since 2015. As of 13 June 2023 he still owns at least 569,345 units of Invitae Corp stock.
You can see the complete history of Robert Nussbaum stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Nussbaum biography
Dr. Robert L. Nussbaum M.D. serves as Chief Medical Officer of the Company. From April 2006 to August 2015, he was chief of the Division of Genomic Medicine at UCSF Health where he also held leadership roles in the Cancer Genetics and Prevention Program beginning in January 2009 and the Program in Cardiovascular Genetics beginning in July 2007. From April 2006 to August 2015, he served as a member of the UCSF Institute for Human Genetics. Prior to joining UCSF Health, Dr. Nussbaum was chief of the Genetic Disease Research Branch of the National Human Genome Research Institute, one of the National Institutes of Health, from 1994 to 2006. He is a member of the National Academy of Medicine and a fellow at the American Academy of Arts and Sciences. Dr. Nussbaum is a board-certified internist and medical geneticist who holds a B.S. in Applied Mathematics from Harvard College and an M.D. from Harvard Medical School in the Harvard-MIT joint program in Health Sciences and Technology. He completed his residency in internal medicine at Barnes-Jewish Hospital and a fellowship in medical genetics at the Baylor College of Medicine.
What is the salary of Robert Nussbaum?
As the Chief Medical Officer of Invitae Corp, the total compensation of Robert Nussbaum at Invitae Corp is $802,739. There are 3 executives at Invitae Corp getting paid more, with Sean George having the highest compensation of $5,319,510.
How old is Robert Nussbaum?
Robert Nussbaum is 70, he's been the Chief Medical Officer of Invitae Corp since 2015. There are 1 older and 18 younger executives at Invitae Corp. The oldest executive at Invitae Corp is Dr. Robert L. Nussbaum, 71, who is the Chief Medical Officer.
What's Robert Nussbaum's mailing address?
Robert's mailing address filed with the SEC is C/O INVITAE CORPORATION, 1400 16TH STREET, SAN FRANCISCO, CA, 94103.
Insiders trading at Invitae Corp
Over the last 10 years, insiders at Invitae Corp have traded over $68,349,838 worth of Invitae Corp stock and bought 2,982,686 units worth $18,086,236 . The most active insiders traders include Bros. Advisors Lp Baker Bro..., Bros. Advisors Lpbaker Feli... et James E Deerfield Mgmt L.P..... On average, Invitae Corp executives and independent directors trade stock every 14 days with the average trade being worth of $540. The most recent stock trade was executed by Robert L Nussbaum on 13 June 2023, trading 7,086 units of NVTA stock currently worth $9,779.
What does Invitae Corp do?
invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.
What does Invitae Corp's logo look like?
Complete history of Robert Nussbaum stock trades at Invitae Corp
Invitae Corp executives and stock owners
Invitae Corp executives and other stock owners filed with the SEC include:
-
Sean George,
Chairman of the Board, President, Chief Executive Officer, Co-Founder -
Shelly Guyer,
Chief Financial Officer -
Katherine Stueland,
Chief Commercial Officer -
Robert Nussbaum,
Chief Medical Officer -
Shelly D. Guyer,
Chief Financial Officer -
Dr. Sean Emerson George Ph.D.,
Co-Founder, Pres, CEO & Director -
Lee Bendekgey,
Chief Policy Officer -
Geoffrey Crouse,
Independent Director -
Eric Aguiar,
Independent Director -
Christine Gorjanc,
Lead Independent Director -
Chitra Nayak,
Independent Director -
Jason Myers,
Director -
Kimber Lockhart,
Director -
Karthik Suri,
Chief Digital Officer -
Thomas Brida,
General Counsel, Secretary -
Robert Werner,
Chief Accounting Officer -
Kenneth Knight,
Chief Operating Officer -
Glenn Medalle,
Head of Talent -
Dr. Robert L. Nussbaum,
Chief Medical Officer -
Robert F. Werner,
Chief Accounting Officer & Principal Accounting Officer -
Desarie French,
Chief Talent Officer -
Laura D'Angelo,
Head of Investor Relations -
Yafei Wen,
Chief Financial Officer -
Layton Wedgeworth,
Chief Technology Officer -
Kenneth D. Knight,
Chief Operating Officer -
Michele Cargill Ph.D.,
Co-Founder, Key Projects & Advisor to the CEO -
Alex Furman,
Co-Founder, Culture Tsar & Head of People Analytics -
Bros. Advisors Lp Baker Bro...,
-
Bros. Advisors Lpbaker Feli...,
-
Mc Nerney & Partners Ii L.P...,
-
Lisa Alderson,
Senior VP, Marketing -
William H Osborne,
Director -
Patty Dumond,
-
Eric Thomas, Mc Nerney & Pa...,
-
James E Deerfield Mgmt L.P....,
-
E Lee Bendekgey,
Chief Operating Officer -
Randal W. Scott,
Director -
Yafei Wen,
Chief Financial Officer -
Robert M. Guigley,
Chief Commercial Officer -
David Sholehvar,
Chief Operating Officer -
Ana J. Schrank,
Chief Financial Officer